173 related articles for article (PubMed ID: 14512134)
1. Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports.
Tobinick EL
Clin Ther; 2003 Aug; 25(8):2279-88. PubMed ID: 14512134
[TBL] [Abstract][Full Text] [Related]
2. Targeted etanercept for discogenic neck pain: uncontrolled, open-label results in two adults.
Tobinick EL
Clin Ther; 2003 Apr; 25(4):1211-8. PubMed ID: 12809967
[TBL] [Abstract][Full Text] [Related]
3. Perispinal TNF-alpha inhibition for discogenic pain.
Tobinick EL; Britschgi-Davoodifar S
Swiss Med Wkly; 2003 Mar; 133(11-12):170-7. PubMed ID: 12715286
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
Tobinick E; Davoodifar S
Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
[TBL] [Abstract][Full Text] [Related]
5. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
Tobinick E; Kim NM; Reyzin G; Rodriguez-Romanacce H; DePuy V
CNS Drugs; 2012 Dec; 26(12):1051-70. PubMed ID: 23100196
[TBL] [Abstract][Full Text] [Related]
6. Immediate neurological recovery following perispinal etanercept years after brain injury.
Tobinick E; Rodriguez-Romanacce H; Levine A; Ignatowski TA; Spengler RN
Clin Drug Investig; 2014 May; 34(5):361-6. PubMed ID: 24647830
[TBL] [Abstract][Full Text] [Related]
7. Perispinal etanercept for neuroinflammatory disorders.
Tobinick E
Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
[TBL] [Abstract][Full Text] [Related]
8. Perineural injection of etanercept as a treatment for postamputation pain.
Dahl E; Cohen SP
Clin J Pain; 2008 Feb; 24(2):172-5. PubMed ID: 18209523
[TBL] [Abstract][Full Text] [Related]
9. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
Tobinick E
CNS Drugs; 2011 Feb; 25(2):145-55. PubMed ID: 21254790
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled, trial of transforaminal epidural etanercept for the treatment of symptomatic lumbar disc herniation.
Freeman BJ; Ludbrook GL; Hall S; Cousins M; Mitchell B; Jaros M; Wyand M; Gorman JR
Spine (Phila Pa 1976); 2013 Nov; 38(23):1986-94. PubMed ID: 24165696
[TBL] [Abstract][Full Text] [Related]
11. Transcending conventional therapies: the role of biologic and other novel therapies.
Sandborn WJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
[TBL] [Abstract][Full Text] [Related]
12. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.
Zanella JM; Burright EN; Hildebrand K; Hobot C; Cox M; Christoferson L; McKay WF
Spine (Phila Pa 1976); 2008 Feb; 33(3):227-34. PubMed ID: 18303453
[TBL] [Abstract][Full Text] [Related]
13. Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study.
Ohtori S; Miyagi M; Eguchi Y; Inoue G; Orita S; Ochiai N; Kishida S; Kuniyoshi K; Nakamura J; Aoki Y; Ishikawa T; Arai G; Kamoda H; Suzuki M; Takaso M; Furuya T; Toyone T; Takahashi K
Spine (Phila Pa 1976); 2012 Mar; 37(6):439-44. PubMed ID: 22020607
[TBL] [Abstract][Full Text] [Related]
14. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
Tobinick EL; Gross H
J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy.
Cohen SP; Wenzell D; Hurley RW; Kurihara C; Buckenmaier CC; Griffith S; Larkin TM; Dahl E; Morlando BJ
Anesthesiology; 2007 Jul; 107(1):99-105. PubMed ID: 17585221
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.
Madhusudan S; Foster M; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Talbot DC; Ganesan TS; Harris AL
Clin Cancer Res; 2004 Oct; 10(19):6528-34. PubMed ID: 15475440
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
Gorman JD; Sack KE; Davis JC
N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
[TBL] [Abstract][Full Text] [Related]
18. Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice.
Dogrul A; Gul H; Yesilyurt O; Ulas UH; Yildiz O
Acta Diabetol; 2011 Jun; 48(2):135-42. PubMed ID: 21104419
[TBL] [Abstract][Full Text] [Related]
19. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.
Bozkurt B; Torre-Amione G; Warren MS; Whitmore J; Soran OZ; Feldman AM; Mann DL
Circulation; 2001 Feb; 103(8):1044-7. PubMed ID: 11222463
[TBL] [Abstract][Full Text] [Related]
20. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
Braun J; McHugh N; Singh A; Wajdula JS; Sato R
Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
